Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -1.40%61 Net Margin % is 18.46% as of Jun. 2026, which is 8% above its 10-year median of 17.07. GuruFocus rates ROCO:1295 with a GF Score™ of 61/100 and a GF Value™ of NT$82.69 (Possible Value Trap). The stock has 12 warning signs investors should review. Among 945 Biotechnology companies, Synbio Tech ranks better than 82.22% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Synbio Tech's Net Income for the
three
months ended in Jun. 2026 was NT$55 Mil. Synbio Tech's Revenue for the
three
months ended in Jun. 2026 was NT$296 Mil. Therefore, Synbio Tech's net margin for the quarter that ended in Jun. 2026 was 18.46%.
The historical rank and industry rank for Synbio Tech's Net Margin % or its related term are showing as below:
ROCO:1295'
s Net Margin % Range Over the Past 10 Years
Min: 12.51 Med: 17.07 Max: 18.69
Current: 14.11
ROCO:1295's Net Margin % is ranked better than 82.22% of 945
companies
in the Biotechnology industry
Industry Median: -76.55
vs ROCO:1295: 14.11
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Synbio Tech Net Margin % Related Terms
Synbio Tech Net Margin % Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, MRNA: Net Margin % Comparison
For the Biotechnology subindustry, Synbio Tech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Net Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a Net Margin % of 18.46% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Synbio Tech and its competitors. This is near median its historical median of 17.07. Over the past decade, Synbio Tech's Net Margin % has ranged from 12.51 to 18.69. According to the industry distribution chart, Synbio Tech ranks #168 out of 945 companies in the Biotechnology industry, placing it in the top 17.8%.
Is Synbio Tech's Net Margin % too high?
Synbio Tech's current Net Margin % of 18.46% is near median its 10-year median of 17.07. Over the past 10 years, this metric has ranged from a low of 12.51 to a high of 18.69. Based on the distribution chart, Synbio Tech ranks #168 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Synbio Tech has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #168 out of 945 companies for Net Margin %. This places Synbio Tech in the top 18% of its industry — outperforming the majority of peers. Historically, Synbio Tech's own Net Margin % has ranged from 12.51 to 18.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Synbio Tech and its competitors. Synbio Tech's current Net Margin % is 18.46%, which is near median its own 10-year median of 17.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Based on GuruFocus' analysis, Synbio Tech (ROCO:1295) is currently considered Possible Value Trap. The stock's GF Value™ is NT$82.69, compared to a current price of NT$45.65 — trading 44.8% below its estimated fair value. The current Net Margin % is 18.46%, which is near median its 10-year median of 17.07. Synbio Tech's overall GF Score™ is 61/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Net Margin % is 18.46% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synbio Tech (ROCO:1295) Overvalued in 2026?
Based on GuruFocus' analysis, Synbio Tech stock appears to be undervalued.
The current stock price of NT$45.65 is trading 44.8% below its estimated GF Value™ of NT$82.69.
GuruFocus considers Synbio Tech to be Possible Value Trap.
Key valuation signals for ROCO:1295:
Net Margin %: 18.46% (near median its 10-year median of 17.07)
GF Value™: NT$82.69 vs. price of NT$45.65 (44.8% below fair value)
No single metric tells the full story. See the ROCO:1295 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
61GF Score
Get the complete analysis for ROCO:1295
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
